MDS PANEL Cytogenetics and FISH del5q del7q del20q Test
Test Name: MDS PANEL Cytogenetics and FISH del5q del7q del20q Test
Components: Sodium Heparin Vacutainer (2ml)
Price: 2550.0 AED
Sample Condition: Bone marrow/Peripheral blood (Transport immediately)
Report Delivery: 5-7 days
Method: Cell Culture + FISH
Test Type: Genetics
Doctor: Gynecologist
Test Department: Pre Test Information
Pre Test Information: MDS PANEL (Cytogenetics + FISH del(5q), del(7q), del(20q)]) can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Details
The MDS Panel is a diagnostic test that combines Cytogenetics and FISH (Fluorescence In Situ Hybridization) techniques to detect specific chromosomal abnormalities in patients suspected of having Myelodysplastic Syndromes (MDS).
Cytogenetics is the study of chromosomes and their abnormalities. In this panel, it is used to analyze the structure and number of chromosomes in the patient’s cells. Abnormalities in the chromosomes can provide valuable information about the presence of MDS or other related disorders.
FISH is a molecular technique that uses fluorescent probes to detect specific genetic sequences on chromosomes. In the MDS Panel, FISH is used to identify three specific chromosomal deletions: del(5q), del(7q), and del(20q). These deletions are commonly associated with MDS and can help confirm the diagnosis.
The presence of del(5q) indicates a deletion of genetic material on the long arm of chromosome 5. This deletion is often found in patients with a subtype of MDS called 5q- syndrome. Similarly, del(7q) indicates a deletion on the long arm of chromosome 7, and del(20q) indicates a deletion on the long arm of chromosome 20. These deletions are also associated with MDS and can help in determining the subtype and prognosis of the disease.
By combining Cytogenetics and FISH techniques, the MDS Panel provides a comprehensive analysis of the patient’s chromosomes and identifies specific deletions that are indicative of MDS. This information is crucial for accurate diagnosis, treatment planning, and prognosis assessment in patients suspected of having MDS.
Test Name | MDS PANEL Cytogenetics and FISH del5q del7q del20q Test |
---|---|
Components | Sodium Heparin Vacutainer (2ml) |
Price | 2550.0 AED |
Sample Condition | Bone marrow\/ Peripheral blood (Transport immediately) |
Report Delivery | 5-7 days |
Method | Cell Culture + FISH |
Test type | Genetics |
Doctor | Gynecologist |
Test Department: | |
Pre Test Information | MDS PANEL (Cytogenetics + FISH del(5q), del(7q), del(20q)]) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
The MDS Panel is a diagnostic test that combines Cytogenetics and FISH (Fluorescence In Situ Hybridization) techniques to detect specific chromosomal abnormalities in patients suspected of having Myelodysplastic Syndromes (MDS). Cytogenetics is the study of chromosomes and their abnormalities. In this panel, it is used to analyze the structure and number of chromosomes in the patient’s cells. Abnormalities in the chromosomes can provide valuable information about the presence of MDS or other related disorders. FISH is a molecular technique that uses fluorescent probes to detect specific genetic sequences on chromosomes. In the MDS Panel, FISH is used to identify three specific chromosomal deletions: del(5q), del(7q), and del(20q). These deletions are commonly associated with MDS and can help confirm the diagnosis. The presence of del(5q) indicates a deletion of genetic material on the long arm of chromosome 5. This deletion is often found in patients with a subtype of MDS called 5q- syndrome. Similarly, del(7q) indicates a deletion on the long arm of chromosome 7, and del(20q) indicates a deletion on the long arm of chromosome 20. These deletions are also associated with MDS and can help in determining the subtype and prognosis of the disease. By combining Cytogenetics and FISH techniques, the MDS Panel provides a comprehensive analysis of the patient’s chromosomes and identifies specific deletions that are indicative of MDS. This information is crucial for accurate diagnosis, treatment planning, and prognosis assessment in patients suspected of having MDS. |